| Literature DB >> 30364427 |
Denis Anywar Arony1, Suzanne Gazda2, David Lagoro Kitara1,3.
Abstract
INTRODUCTION: Nodding syndrome (NS) is associated with high anion gap, biotinidase and acetyl carnitine deficiency, vitamin B6 and D deficiency and internal displacement. The objective of this study was to conduct a metabolic analysis on NS children and review literature on its similarities with ASD.Entities:
Keywords: Gulu university; IDPs; Nodding syndrome; autism spectrum disorder; metabolic disorder
Mesh:
Substances:
Year: 2018 PMID: 30364427 PMCID: PMC6195236 DOI: 10.11604/pamj.2018.30.115.13634
Source DB: PubMed Journal: Pan Afr Med J
Figure 1Year of birth and onset of nodding (Kitara et al, 2017)
Figure 2Duration in IDP in relation to age of NS onset (Kitara et al, 2017)
Figure 3Relationship between NS and birth orders of their NS siblings (Kitara et al, 2017)
Figure 4Median plasma biotinidase level by age of NS children
Figure 5The percentage biotinidase deficiency in NS children
Figure 6The percentage acetyl carnitine deficiency in NS children
The bivariate analysis of factors associated with nodding syndrome
| Variables | (χ2) | p-value | Fisher's test |
|---|---|---|---|
| Sex of NS child (Male) | 1.134 | 0.287 | 0.245 |
| Age at NS onset | 10.218 | 0.511 | 0.477 |
| NS child was in IDPs |
|
|
|
| NS child had other siblings with NS |
|
|
|
| Length of IDP stay | 7.500 | 0.277 | 0.277 |
| Birth order of NS child | 9.680 | 0.377 | 0.270 |
| School Attendance | 0.761 | 0.683 | 1.000 |
| Caretaker is a mother |
|
|
|
| >50 nodding episodes since NS onset |
|
|
|
| Epileptic fits experienced by NS child |
|
|
|
| Disorientation | 1.907 | 0.385 | 0.327 |
| Loss of consciousness |
|
|
|
| Localized Tonic clonic seizures | 0.598 | 0.742 | 1.000 |
| Generalized Tonic-clonic convulsions | 4.186 | 0.123 | 0.151 |
| Urinary incontinence | 3.139 | 0.208 | 0.367 |
| Sleeping after nodding episodes | 3.220 | 0.200 | 0.252 |
| Confusion after fits/Nodding | 4.430 | 0.107 | 0.327 |
| Rhythmic jerking during nodding episodes | 2.616 | 0.270 | 0.236 |
| Good sleep pattern | 1.529 | 0.675 | 1.000 |
| Aggressive behavior after fits/nodding | 2.188 | 0.139 | 0.233 |
| Foaming in the mouth |
|
|
|
| Perceptual disturbances before/after nodding | 1.155 | 0.283 | 0.410 |
| Presence of visual hallucinations | 3.447 | 0.486 | 0.384 |
| History of mental illness in the family |
|
|
|
| Low serum Biotinidase levels |
|
|
|
| Low serum Acetyl Carnitine levels |
|
|
|
| Good family social support to NS child |
|
|
|
Multivariable logistic regression analysis of the associated factors of NS
| Variables | Mean | (95% CI) | p-value |
|---|---|---|---|
| Low BMI | 16.9 | 16.10,17.75 | 0.42 |
| Low MUAC | 19.9 | 19.02,20.76 | 0.38 |
| Duration in IDPs (yrs) | 4.8 | 4.48,5.21 | 0.92 |
| Low serum biotinidase |
|
|
|
| Low Acetyl Carnitine |
|
|
|
| Age at NS onset (yrs) | 8.02 | 7.03,9.01 | 0.64 |
| Current age(yrs) | 14.08 | 13.24,14.92 | 0.77 |
| Normal Urate/Creatinine ratios | 0.25 | 0.20,0.30 | 0.08 |
| Normal Urate level | 0.23 | 0.20,0.25 | 0.45 |
The normal ranges for serum biotinidase is [2.5-7.5IU/L; serum acetyl carnitine [25-54μmol/L in male Children≤17 years and 19-51μmol/L in female children≤17 years; Urate [0.11-0.3mmol/L]; Urate/creatinine ratio [0.3-0.8mmol/L]
Figure 7The oxidative stress and possible exposures after birth in the induction of autism
Metabolic disorders associated with epilepsy and autism spectrum disorder
| Disorder | Clinical features | Diagnostic testing |
|---|---|---|
|
| ||
| Mitochondrial disease | Developmental regression, gross motor delay, fatigability, ataxia and gastrointestinal abnormalities | Fasting serum lactate, pyruvate, acylcarnitine, amino acids and urine organic acids |
| Creatine metabolism disorder | Developmental regression, mental retardation, dyskinesia, and family history of x-linked mental retardation | Magnetic resonance spectroscopy, Urine and serum creatine and guanidionacetic acid |
|
| Low birth weight, failure to thrive, poor feeding, eczema, and congenital structural abnormalities of the heart, gastrointestinal tract, genitalia, Kidney, limbs, face and brain | Blood 7-dehydrocholesterol and cholesterol, DHCR7 sequencing |
|
| Ataxia, pyramidal signs, acquired microcephaly, dyskinesias, and visual and hearing loss | Folate receptor alpha autoantibody, Cerebrospinal fluid 5-methyltetrahydrofolate |
| Pyridoxine-dependent and pyridoxine-responsive seizures | Mental retardation, breath-holding, aerophagia, and self injurious behaviour | Pyridoxine trial, plasm and CSF fluid pipecolic acid, urine @aminoadipic semi aldehyde, ALDH7A 1 sequencing |
| Biotinidase deficiency | Developmental delays, seborrheic dermatitis, alopecia, feeding difficulties, vomiting, diarrhoea, brain atrophy and ataxia | Biotinidase activity, BTD gene sequencing |
| Carnitine biosynthesis deficiency | Nondysmorphic male–male siblings with autism spectrum disorder | Plasma and/or urine 6-N-trimethyllysine, 3-hydroxy-6-N-trimethyllysine, and gamma butyrobetaine |
|
| Global developmental delay, myoclonus, hallucinations, ataxia, choreoathosis and dystonia | Urine gamma-hydroxybutyric acid |
|
| Global developmental delay, microcephaly, distinct facies, growth retardation, mental retardation, cerebral vermis hypoplasia, brain atrophy, excessive laughter and extreme happiness | Urine and /or cerebrospinal fluid succinyladenosine |
| Nucleotidase-associated PDD | Hyperactivity, compulsiveness, speech abnormalities, ataxia, abnormal gait, and frequent infections | Urine uridine |
| Hyperuricosuric autism | Altered sensory awareness, ataxia, and fine motor deficits | 24-hour urine urate |
| Phosphoribosylpyrophosphate synthetase deficiency | Developmental delay and ataxia | Urine uric and orotic acids; Complete blood count |
|
| Global developmental delay, mental retardation, microcephaly, spasticity, ataxia, poor growth, poor skin pigmentation and aggressive behaviour | Serum phenylalanine |
| Branched-chain ketoacid dehydrogenase, Kinase deficiency | Intellectual disability and consanguinity | Plasma and cerebrospinal fluid branched-chain amino acids |
| Altered tryptophan metabolism | No specific features besides autism spectrum disorder | Reduced cellular generation of nicotinamide adenine dinucleotide |
|
| Protein intolerance, temperature instability, ataxia, episodic somnolence and lethargy, cyclic vomiting and psychosis | Plasma ammonia and amino acids, Urinary orotic acid |
|
|